Challenging Case of Multisystem Inflammatory Syndrome in a 19- Year Old Female: A Case Report
Journal
BANTAO Journal
Date Issued
2022
Author(s)
Spasovska Vasilova, Adrijana
Milenkova, Mimoza
Filipovski, Stefan
DOI
https://www.bantaojournal.com/_files/ugd/356e34_80e909e3c5834c4a8a1f2adcbfe3a076.pdf
Abstract
Introduction. In comparison to older adults, SARSCoV-2, leads to a mild illness in children and young
adults typically manifested with fever, cough and
gastrointestinal symptoms. However, the multisystem
inflammatory syndrome in children and young adults
(MISC) emerged during the coronavirus disease in
2019 pandemic.
Case report. We report a challenging case of a 19-
year old female patient with signs and symptoms of
multisystem inflammatory syndrome and SARS-CoV2 infection, most probably as a post infectious disease
with onset between 2 to 4 weeks after the infection. Its
clinical symptoms may have overlaped with classical
Kawasaki disease (systemic vasculitis) or Kawasakilike syndrome (atypical) with fever, gastrointestinal
symptoms, rash, conjunctival injection, hypotension,
sore throat, mucosal changes with a relative lack of
severe respiratory disease, myocarditis, hypoalbuminemia
and elevated inflammatory markers. And indeed, the
clinical presentation of COVID-19 in young adults
resembles Kawasaki disease with gastrointestinal manifestations to severe inflammation with myocarditis.
Conclusion. Timely diagnosis and proper treatment of
the multisystem inflammatory syndrome and SARSCoV-2 infection are real challenge requiring multidisciplinary approach and tertiary resources.
adults typically manifested with fever, cough and
gastrointestinal symptoms. However, the multisystem
inflammatory syndrome in children and young adults
(MISC) emerged during the coronavirus disease in
2019 pandemic.
Case report. We report a challenging case of a 19-
year old female patient with signs and symptoms of
multisystem inflammatory syndrome and SARS-CoV2 infection, most probably as a post infectious disease
with onset between 2 to 4 weeks after the infection. Its
clinical symptoms may have overlaped with classical
Kawasaki disease (systemic vasculitis) or Kawasakilike syndrome (atypical) with fever, gastrointestinal
symptoms, rash, conjunctival injection, hypotension,
sore throat, mucosal changes with a relative lack of
severe respiratory disease, myocarditis, hypoalbuminemia
and elevated inflammatory markers. And indeed, the
clinical presentation of COVID-19 in young adults
resembles Kawasaki disease with gastrointestinal manifestations to severe inflammation with myocarditis.
Conclusion. Timely diagnosis and proper treatment of
the multisystem inflammatory syndrome and SARSCoV-2 infection are real challenge requiring multidisciplinary approach and tertiary resources.